TY  - GEN
AU  - McCubrey,J A
AU  - Abrams,S L
AU  - Ligresti,G
AU  - Misaghian,N
AU  - Wong,E W T
AU  - Steelman,L S
AU  - Bäsecke,J
AU  - Troppmair,J
AU  - Libra,M
AU  - Nicoletti,F
AU  - Molton,S
AU  - McMahon,M
AU  - Evangelisti,C
AU  - Martelli,A M
TI  - Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
SN  - 1476-5551
PY  - 2008///1211
KW  - Animals
KW  - Annexin A5
KW  - metabolism
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Caspases
KW  - Cells, Cultured
KW  - Cysteine Proteinase Inhibitors
KW  - pharmacology
KW  - Doxorubicin
KW  - Drug Resistance
KW  - Enzyme Activation
KW  - Enzyme Inhibitors
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - antagonists & inhibitors
KW  - Genes, Dominant
KW  - Hematopoietic Stem Cells
KW  - Imidazoles
KW  - Leupeptins
KW  - Mice
KW  - Mitogen-Activated Protein Kinase Kinases
KW  - Phosphorylation
KW  - Piperazines
KW  - Proto-Oncogene Proteins c-mdm2
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Signal Transduction
KW  - Tumor Suppressor Protein p53
KW  - raf Kinases
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2008.207
ER  -